Abnormal placentation in the repeat cesarean section.

Authors

  • Olga CERNEȚCHI Departamentul de Obstetrică și Ginecologie, IP USMF „Nicolae Testemiţanu”
  • Oleg POTACEVSCHI Departamentul de Obstetrică și Ginecologie, IP USMF „Nicolae Testemiţanu”

DOI:

https://doi.org/10.52692/1857-0011.2021.3-71.35

Keywords:

abnormal placentation, cesarean section, placenta accreta, placenta previa, hysterectomy

Abstract

Introduction. Abnormal placentation is a challenge of diagnostic and treatment for all perinatal health professionals. The most important risk factors for the development of pathological placental invasion have been identified as birth by previous cesarean section, placenta praevia and advanced maternal age. Antenatal diagnosis can reduce morbidity and mortality; it is usually determined by grayscale ultrasound and confirmed by nuclear magnetic resonance, which can better delimit the degree of placental invasion. The management of pathological placental invasion is one complex and multidisciplinary, because abnormal placentation is associated with significant maternal morbidity and mortality.Objective: to present a literature review on the topic of abnormal placentation based on international studies.Methods and materials: research in international databases by applying in the MedLine search systems, Web of Science keywords – abnormal placentation, cesarean section, placenta accreta, placenta previa, hysterectomy.Results. With the identification of risk factors and the possibilities of obstetric ultrasonography, many cases of placen-ta accreta are diagnosed prenatally. However, not all patients have access to ultrasound, skilled ultrasound or experienced radiologists or obstetricians who can make these prenatal diagnoses. Due to these limitations, cases of abnormal placenta can only be encountered at birth. Therefore, it is important for all obstetricians to be familiar with the epidemiology, risk factors, diagnosis and management of these potentially very morbid and fatal pathologies of abnormal placentation.

Author Biographies

Olga CERNEȚCHI, Departamentul de Obstetrică și Ginecologie, IP USMF „Nicolae Testemiţanu”

dr. hab. șt. med., prof. univ.

Oleg POTACEVSCHI, Departamentul de Obstetrică și Ginecologie, IP USMF „Nicolae Testemiţanu”

student-doctorand

References

Allen L., Jauniaux E., Hobson S., Papillon-Smith J., Belfort M.A. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. In: Int. J. Gynaecol. Obstet. 2018; 140(3): 281-290.

Baldwin H.J., Patterson J.A., Nippita T.A., et al. Antecedents of Abnormally Invasive Placenta in Primiparous Women: Risk Associated with Gynecologic Procedures. In: Obstet. Gynecol. 2018; 131(2): 227-233.

Boatin A., Schlotheuber A., Betran A.P. Within country inequalities in cesarean section rates: observational study of 72 low- and middle-income countries. In: Obstet. Gynecol. Surv. 2018; 73(6): 333–334.

Chantraine F., Langhoff-Roos J. Abnormally invasive placenta--AIP. Awareness and pro-active management is necessary. In: Acta Obstet. Gynecol. Scand. 2013; 92(4): 369-371.

Collins S.L. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. In: Am. J. Obstet. Gynecol. 2019; 220(6): 511-526.

Collins S.L., Stevenson G.N., Al-Khan A., et al. Three-Dimensional Power Doppler Ultrasonography for Diagnosing Abnormally Invasive Placenta and Quantifying the Risk. In: Obstet. Gynecol. 2015; 126(3): 645-653.

Cresswell J.A., Ronsmans C., Calvert C., Filippi V. Prevalence of placenta praevia by world region: a systematic review and meta-analysis. In: Trop. Med. Int. Heath. 2013; 18: 712–724.

Dilly Anumba, Shehnaaz Jivraj. Antenatal Disorders for the MRCOG and Beyond. 2nd edition. Antepartum haemorrage (Chapter 2). Cambridge University Press 2016. ISBN:9781107585799 https://doi.org/10.1017/CBO9781107585799

Fitzpatrick K.E., Sellers S., Spark P., et al. Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study. In: PLoS ONE. 2012; 7(12): e52893. Disponibil pe: DOI: 10.1371/journal.pone.0052893

Franchini M., Franchi M., Bergamini V., et al: A critical review of the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. In: Semin. Thromb Hemost. 2008; 34: 104-112.

Garmi G., Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. In: Obstet. Gynecol. Int. 2012; 2012(8): 873929.

Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. In: Am. J. Obstet. Gynecol. 2017; 217(1): 27–36.

Jauniaux E., Bhide A., Kennedy A., et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel.

In: Int. J. Gynaecol. Obstet. 2018; 140(3): 274-280. 14. Jimbo M., Sekizawa A., Sugito Y., et al: Placenta increta: Postpartum monitoring of plasma cell-free fetal DNA. In: Clin. Chem. 2003; 49: 1540-1541.

Jing L., Wei G. Effect of site of placentation on pregnancy outcomes in patients with placenta previa. In:PLoS One. 2018; 13: e0200252.

Karami M., Jenabi E., Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. In: J. Matern. Fetal Neonatal Med. 2018; 31: 1940–1947.

Kashani E., Azarhoush R. Peripartum hysterectomy for primary postpartum hemorrhage: 10 years evaluation. In: European Journal of Experimental Biology. 2012; 2(1): 32-36.

Khong T.Y. The pathology of placenta accreta, a worldwide epidemic. In: J. Clin. Pathol. 2008; 61: 1243-1246.

Klar M., Michels K.B. Cesarean section and placental disorders in subsequent pregnancies – a meta-analysis. In: J. Perinat. Med. 2014; 42: 571–583.

Lax A., Prince M.R., Mennitt K.W., et al. The value of specific MRI features in the evaluation of suspected placental invasion. In: Magn Reson Imaging. 2007; 25: 87-93.

Li J., Zhang N., Zhang Y., et al. Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no? In: Gynecol. Endocrinol. 2019; 35(7): 631-634. Disponibil pe:DOI: 10.1080/09513590.2019.1576607

Maddalena Morlando and Sally Collins. Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies. In: Int. J. Women’s Health. 2020; 12:1033–1045.

Masoumeh Birjandi, D. Nanu. Frecvența operațiilor cezariene în România și la nivel global. In: Revista Medicală Română. 2019; 66(2): 118-121.

Okendrajit Singh O., Pukhrambam G.D., Bidya Devi A., et al. Abnormal placentation following previous caesarean section delivery – a ten-years study in peripartum hysterectomy cases. In: J. Evid. Based Med. Healthc. 2020; 7(4): 168-172. Disponibil pe: DOI: 10.18410/jebmh/2020/35.

Parvin Z., S. Das, L. Naher, S.K. Sarkar, K. Fatema. Relation of placenta praevia with previous lower segment caesarean section (lucs) in our clinical practice. In: Faridpur Med. Coll. J. 2017; 12(2): 75-77.

Pijnenborg R., Vercruysse L. Shifting concepts of the fetal-maternal interface: A historical perspective. In: Placenta. 2008; 22: S20-S25.

Roustaei Z., Vehvilainen-Julkunen K., Tuomainen T.P., Lamminpaa R., Heinonen S. The effect of advanced maternal age on maternal and neonatal outcomes of placenta previa: a register-based cohort study. In: Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 227: 1–7.

Samuel T. Bauer, and Clarissa Bonanno. Abnormal Placentation. In: Semin. Perinatol. 2009; 33: 88-96.

Sekizawa A., Jimbo M., Saito H., et al: Increased cell-free fetal DNA in plasma of two women with invasive placenta. In: Clin. Chem. 2002; 48: 353-354.

Sentilhes L., Goffinet F., Kayem G. Management of placenta accreta. In: Acta Obstet. Gynecol. Scand. 2013; 92(10): 1125-1134.

Sentilhes L., Kayem G., Chandraharan E., Palacios-Jaraquemada J., Jauniaux E. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. In: Int. J. Gynaecol. Obstet. 2018; 140(3): 291-298.

Shoko Hamada, Junichi Hasegawa, Masamitsu Nakamura, et al. Ultrasonographic findings of placenta lacunae and a lack of a clear zone in cases with placenta previa and normal placenta. In: Prenat. Diagn. 2011; 31:1062–1065.

Silver R.M., Landon M.B., Rouse D.J., et al. Maternal morbidity associated with multiple repeat cesarean deliveries. In: Obstet. Gynecol. 2006; 107: 1226-1232.

Tantbirojin P., Crum C.P., Parast M.M. Pathophysiology of placenta creta: The role of decidua and extravillous cytotrophoblast. In: Placenta. 2008; 29: 639645.

Timmermans S., van Hof A.C., Duvekot J.J. Conservative management of abnormally invasive placentation. In: Obstet. Gynecol. Surv. 2007; 62: 529-539.

Upson K., Silver R.M., Greene R., et al. Placenta accreta and maternal morbidity in the Republic of Ireland, 2005–2010. In: J. Matern. Fetal Neonatal Med. 2014; 27(1): 24–29.

Warshak C.R., Eskaner R., Hull A.D., et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. In: Obstet. Gynecol. 2006; 108: 573-581.

Zhang L. et al. Effect of previous placenta previa on outcome of next pregnancy: a 10-year retrospective cohort study. In: BMC Pregnancy and Childbirth. 2020; 20: 212.

Zhou J., Li J., Yan P., et al. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete. In: Placenta. 2014; 35(9): 691-695. Disponibil pe: DOI: 10.1016/j.placenta.2014.07.007.

Краснопольский В.И., Логутова Л.С. Совре- менная концепция родоразрешения и перинатальная смертность. B: Медицинский совет. 2014; 9: 54–58.

Степанова Р.Н. Проблемы родоразрешения женщин после предшествующего кесарева сечения. B: Ульяновский медико-биологический журнал. 2018; 3: 19–28.

Published

2021-11-17

Issue

Section

Research Article